Phase II HDM-SPIRE Safety and Efficacy Study
Launched by CIRCASSIA LIMITED · May 27, 2014
Trial Information
Current as of August 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female, aged 18-65 years.
- • Moderate to severe rhinoconjunctivitis on exposure to HDM for at least 1 years.
- • Mean TRSS ≥10
- • Positive skin prick test to Der p and Der f.
- • Dep p and Der f specific IgE ≥0.7 kU/L
- Exclusion Criteria:
- • Diagnosis of asthma requiring Global Initiative for Asthma (GINA) Step 3 (www.ginasthma.org)or higher treatment
- • FEV1 \<80% of predicted.
- • Clinically significant confounding symptoms of allergy to seasonal allergens during the final evaluation period.
- • Significant symptoms of another clinically relevant illness that is likely to affect scoring of rhinoconjunctivitis symptoms.
- • Clinically relevant abnormalities detected on physical examination.
- • History of severe drug allergy, severe angioedema or anaphylactic reaction to food.
About Circassia Limited
Circassia Limited is a biopharmaceutical company focused on developing innovative therapies for respiratory diseases. With a commitment to improving patient outcomes, Circassia leverages advanced technologies and rigorous clinical research to bring forward novel treatments that address unmet medical needs. The company's portfolio includes targeted therapies for asthma and chronic obstructive pulmonary disease (COPD), highlighting its dedication to enhancing the quality of life for individuals living with these conditions. Through strategic partnerships and a robust pipeline, Circassia aims to lead advancements in respiratory medicine while ensuring safety and efficacy in its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Pittsburgh, Pennsylvania, United States
San Antonio, Texas, United States
Birmingham, Alabama, United States
Seattle, Washington, United States
Berlin, , Germany
Roma, , Italy
Tampa, Florida, United States
Iowa City, Iowa, United States
Rochester, New York, United States
Portland, Oregon, United States
South Burlington, Vermont, United States
Seattle, Washington, United States
Milwaukee, Wisconsin, United States
London, Ontario, Canada
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Barcelona, , Spain
Minneapolis, Minnesota, United States
Dallas, Texas, United States
Berlin, , Germany
Hamburg, , Germany
Amsterdam, , Netherlands
Sabadell, Barcelona, Spain
Birmingham, Alabama, United States
Orange, California, United States
San Diego, California, United States
Providence, Rhode Island, United States
Madison, Wisconsin, United States
Long Beach, California, United States
Gaithersburg, Maryland, United States
Cincinnati, Ohio, United States
Vancouver, Washington, United States
Canton, Ohio, United States
Genova, , Italy
Hamilton, Ontario, Canada
Windsor, Ontario, Canada
Walnut Creek, California, United States
Tampa, Florida, United States
Tulsa, Oklahoma, United States
Bangor, Maine, United States
Barcelona, , Spain
Tallahassee, Florida, United States
Dallas, Texas, United States
Saint Louis, Missouri, United States
Hamburg, , Germany
Santander, , Spain
Minneapolis, Minnesota, United States
Ottawa, Ontario, Canada
Plano, Texas, United States
Quebec City, Quebec, Canada
Milano, , Italy
Sevilla, , Spain
Pavia, , Italy
Medford, Oregon, United States
Sevilla, , Spain
Roseville, California, United States
Plymouth, Minnesota, United States
Asheville, North Carolina, United States
Bethesda, Maryland, United States
Milano, , Italy
High Point, North Carolina, United States
San Diego, California, United States
Brockton, Massachusetts, United States
Dresden, , Germany
Evansville, Indiana, United States
Waterbury, Connecticut, United States
Siena, , Italy
High Point, North Carolina, United States
Essen, , Germany
Normal, Illinois, United States
Bellingham, Washington, United States
Huntington Beach, California, United States
Owensboro, Kentucky, United States
Mission Viejo, California, United States
Rolling Hills Estates, California, United States
Redwood City, California, United States
Bethlehem, Pennsylvania, United States
Ocean City, New Jersey, United States
Napa, California, United States
Trois Rivieres, Quebec, Canada
Roseville, California, United States
Cape Town, Western Cape, South Africa
Almere, , Netherlands
Stockbridge, Georgia, United States
Kerrville, Texas, United States
Parma, , Italy
St Romuald, Quebec, Canada
Verona, New Jersey, United States
Dresden, Saxony, Germany
Durban, Kwazulu Natal, South Africa
Greenfield, Wisconsin, United States
Bellevue, Nebraska, United States
Henrico, Virginia, United States
Santander, Cantabria, Spain
Essen, Nordrhein Westfalen, Germany
Goch, Nordrhein Westfalen, Germany
Teaneck, New Jersey, United States
Beek, , Netherlands
Blue Bell, Pennsylvania, United States
Rockville Centre, New York, United States
Reims, Marne, France
Heidelberg, Baden Wuerttemberg, Germany
London, , Canada
Shiloh, Illinois, United States
Niagara, Ontario, Canada
Gironde, Pessac, France
Bas Rhin, Strasbourg, France
Meurthe Et Moselle, Vandoeuvre Les Nancy, France
Ancona, Torrette Di Ancona, Italy
Ottawa, Kwazulu Natal, South Africa
Umkomaas, Kwazulu Natal, South Africa
Girona, Catalonia, Spain
San Sebastian, Guipuzcoa, Spain
Pamplona, Navarre, Spain
Bilbao, Vizcaya, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials